Inhibition of nitric oxide and tumor necrosis factor-alpha by moutan cortex in activated mouse peritoneal macrophages

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 5, 2007, Pages 912-916

  Chung, Hwan Suck ^a   Kang, Moonkyu ^a   Cho, Chongwoon ^a   Parvez, Shoukat ^a,c   Park, Chong Heong ^b   Kim, Dongwoo ^b   Oh, Joonghwan ^b   Kim, Hongyeoul ^a   Shin, Minkyu ^a   Hong, Moochang ^a   Kim, Yangseok ^a   Bae, Hyunsu ^a  

^a Kyung Hee University   (South Korea)

^b Gachon University   (South Korea)

^c NATIONAL INSTITUTE FOR BIOTECHNOLOGY AND GENETIC ENGINEERING NIBGE   (Pakistan)

Author keywords

Anti inflammatory effect; Moutan cortex (MC); Nitric oxide; Peritoneal macrophage; Tumor necrosis factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PAEONIA SUFFRUTICOSA EXTRACT; RECOMBINANT GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PAEONIA SUFFRUTICOSA; PERITONEUM MACROPHAGE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOTTING, WESTERN; CELL NUCLEUS; CELL SURVIVAL; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUGS, CHINESE HERBAL; INTERFERON-GAMMA, RECOMBINANT; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PAEONIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34248166979     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.912     Document Type: Article

References (32)

1. Oh G. S., Pae H. O., Choi B. M., Jeong S., Oh H., Oh C. S., Rho Y. D., Kim D. H., Shin M. K., Chung H. T., J. Ethnopharmacol., 84, 85-89 (2003).
2. Li G., Seo C. S., Lee K. S., Kim H. J., Chang H. W., Jung J. S., Song D. K., Son J. K., Arch. Pharm. Res., 27, 1123-1126 (2004).
3. Nathan C., Faseb. J., 6, 3051-3064 (1992).
4. Gantt K. R., Goldman T. L., McCormick M. L., Miller M. A., Jeronimo S. M., Nascimento E. T., Britigan B. E., Wilson M. E., J. Immunol., 167, 893-901 (2001).
5. Tracey K. J., Cerami A., Annu. Rev. Med., 45, 491-503 (1994).
6. Tracey K. J., Fong Y., Hesse D. G., Manogue K. R., Lee A. T., Kuo G. C., Lowry S. F., Cerami A., Nature (London), 330, 662-664 (1987).
7. Baker S. J., Reddy E. P., Oncogene, 17, 3261-3270 (1998).
8. Vilcek J., Lee T. H., J. Biol. Chem., 266, 7313-7316 (1991).
9. Sweet M. J., Hume D. A., J. Leukoc. Biol., 60, 8-26 (1996).
10. Kuprash D. V., Udalova I. A., Turetskaya R. L., Rice N. R., Nedospasov S. A., Oncogene, 11, 97-106 (1995).
11. Lin Y. L., Lin J. K., Mol. Pharmacol., 52, 465-472 (1997).
12. Xie Q. W., Cho H. J., Calaycay J., Mumford R. A., Swiderek K. M., Lee T. D., Ding A., Troso T., Nathan C., Science, 256, 225-228 (1992).
13. Schreiber E., Harshman K., Kemler I., Malipiero U., Schaffner W., Fontana A., Nucleic Acids Res., 18, 5495-5503 (1990).
14. Lowenstein C. J., Alley E. W., Raval P., Snowman A. M., Snyder S. H., Russell S. W., Murphy W. J., Proc. Natl. Acad. Sci. U.S.A., 90, 9730-9734 (1993).
15. Yao J., Mackman N., Edgington T. S., Fan S. T., J. Biol. Chem., 272, 17795-17801 (1997).
16. Ji Y., Akerboom T. P., Sies H., Thomas J. A., Arch. Biochem. Biophys., 362, 67-78 (1999).
17. Sies H., Mehlhorn R., Arch. Biochem. Biophys., 251, 393-396 (1986).
18. Arteel G. E., Kadiiska M. B., Rusyn I., Bradford B. U., Mason R. P., Raleigh J. A., Thurman R. G., Mol. Pharmacol., 55, 708-715 (1999).
19. Moncada S., Palmer R. M., Higgs E. A., Pharmacol. Rev., 43, 109-142 (1991).
20. Chiou W. F., Sung Y. J., Liao J. F., Shum A. Y., Chen C. F., J. Nat. Prod., 60, 708-711 (1997).
21. Kobuchi H., Droy-Lefaix M. T., Christen Y., Packer L., Biochem. Pharmacol., 53, 897-903 (1997).
22. Raso G. M., Meli R., Di Carlo G., Pacilio M., Di Carlo R., Life Sci., 68, 921-931 (2001).
23. Ryu J. H., Lee H. J., Jeong Y. S., Ryu S. Y., Han Y. N., Arch. Pharm. Res., 21, 481-484 (1998).
24. Firestein G. S., Boyle D., Bullough D. A., Gruber H. E., Sajjadi F. G., Montag A., Sambol B., Mullane K. M., J. Immunol., 152, 5853-5859 (1994).
25. Cohan V. L., Showell H. J., Fisher D. A., Pazoles C. J., Watson J. W., Turner C. R., Cheng J. B., J. Pharmacol. Exp. Ther., 278, 1356-1361 (1996).
26. Moreira A. L., Sampaio E. P., Zmuidzinas A., Frindt P., Smith K. A., Kaplan G., J. Exp. Med., 177, 1675-1680 (1993).
27. Mandrika I., Muceniece R., Wikberg J. E., Biochem. Pharmacol., 61, 613-621 (2001).
28. Pan M. H., Lin-Shiau S. Y., Lin J. K., Biochem. Pharmacol., 60, 1665-1676 (2000).
29. Spink J., Cohen J., Evans T. J., J. Biol. Chem., 270, 29541-29547 (1995).
30. Kopp E. B., Ghosh S., Adv. Immunol., 58, 1-27 (1995).
31. Baeuerle P. A., Henkel T., Annu. Rev. Immunol., 12, 141-179 (1994).
32. Chen Y., Yang L., Lee T. J., Biochem. Pharmacol., 59, 1445-1457 (2000).